Nada Alsuhebany Profile
Nada Alsuhebany

@NAlsuhebany

Followers
395
Following
635
Media
5
Statuses
266

Assistant Professor @KSAU_HS | HemOnc Consultant Clin Pharmacist @NGHA || PharmD, BCOP | PGY2 Oncology @MUSCHealth | PGY1 @UAZPharmacy | @UICPharm alum

Riyadh, KSA
Joined August 2016
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@NAlsuhebany
Nada Alsuhebany
3 years
Officially BCOP certified! ✅🥳🥳
5
0
31
@NAlsuhebany
Nada Alsuhebany
6 months
Thrilled to join the scientific committee as a co-chair for #SSCP24 ! Looking forward to teaming up with brilliant minds to foster scientific excellence ✨ Stay tuned for exciting updates and save the date, 11-14 September 2024.
Tweet media one
1
0
27
@NAlsuhebany
Nada Alsuhebany
2 months
Join our last SOPA Club of 2024! 😍
@sopa_sos
SOPA
2 months
🎉 Exciting News! 🎉 يسرنا ان نعلن عن انعقاد الجلسة الخامسة و الاخيرة لهذا العام من SOPA CLUB 24 والتي تناقش احدث الدراسات والطرق العلاجيه في مجال السرطان وامراض الدم. The SOPA Club, led by our dedicated SOPA Trainee Support Team and delivered by our #Hemonc pharmacy
Tweet media one
0
8
15
0
1
11
@NAlsuhebany
Nada Alsuhebany
17 days
مع كل خطوة نحو المستقبل، نظل متمسكين بتاريخنا العريق، ونبني على أسسه المتينة لنحقق طموحنا 💚 #نحلم_ونحقق #SSCP
0
0
11
@NAlsuhebany
Nada Alsuhebany
1 year
Join us in our first SOPA YPR Program‼️😍
@sopa_sos
SOPA
1 year
Don't miss your chance to be part of the very first SOPA YPR Program. Limited seats available! Secure your spot now! To register: See you on Oct 13th! 🗓️👋 #SOPAYPR #HemOnc #Oncology #Pharmacy
Tweet media one
0
16
11
0
1
11
@NAlsuhebany
Nada Alsuhebany
2 years
نتشرف بحضوركم جميعاً 🌸💕
@KSAU_HS_COP
College of Pharmacy | كلية الصيدلة
2 years
كُنَّ بخير دائماً! #رايتك_وردية
Tweet media one
Tweet media two
0
3
9
0
1
6
@NAlsuhebany
Nada Alsuhebany
2 months
Please Join Dr. @AtheerAldairem this Thursday!! 😍
@sscpinfdpsn
SSCP ID PSN
2 months
Our lecture next Thursday ⬇️
Tweet media one
0
2
4
0
1
5
@NAlsuhebany
Nada Alsuhebany
3 years
@SaraBanter @MDAndersonNews congrats Sara!! 😍
0
0
2
@NAlsuhebany
Nada Alsuhebany
1 month
Join our last SOPA Club of 2024!! 😍
@sopa_sos
SOPA
2 months
🎉 Exciting News! 🎉 يسرنا ان نعلن عن انعقاد الجلسة الخامسة و الاخيرة لهذا العام من SOPA CLUB 24 والتي تناقش احدث الدراسات والطرق العلاجيه في مجال السرطان وامراض الدم. The SOPA Club, led by our dedicated SOPA Trainee Support Team and delivered by our #Hemonc pharmacy
Tweet media one
0
8
15
0
1
4
@NAlsuhebany
Nada Alsuhebany
2 years
It was a pleasure meeting @Dr_AmerZeidan and catching up with all the hem side in highlights of ASH in NYC! #ASH
1
0
2
@NAlsuhebany
Nada Alsuhebany
2 years
Join us tomorrow at 2:30 PM 😍
@sopa_sos
SOPA
2 years
Sugemalimab in metastatic non small cell cancer is the next journal club. To register please use the following link: Don't miss it!
Tweet media one
0
4
12
0
0
3
@NAlsuhebany
Nada Alsuhebany
5 years
@BarthRx33 @KAlfond_PharmD @BWDionne This is how I remember it: ⬆️ seNsitivity = ⬇️ false Negatives ⬆️sPecificty = ⬇️ false Positives
0
0
3
@NAlsuhebany
Nada Alsuhebany
2 years
It was my pleasure to be an evaluator today at the Resident Research Day 2022. Congratulations to all residents for this accomplishment!
@Aldemerdash_A
Ahmed Aldemerdash أحمد الدمرداش
2 years
Congratulations to the top 3 winners: 1st Place: Dr. Sara Abutaily 2nd Place: Dr. Asma Alzubaidi 3rd Place: Dr. Nisir Bifari
Tweet media one
Tweet media two
Tweet media three
0
12
38
0
0
3
@NAlsuhebany
Nada Alsuhebany
2 years
Join us tomorrow! 😍
@sopa_sos
SOPA
2 years
Dostarlimab in locally advanced recatal cancer is the next journal club. To register please use the following link: Don't miss it!
Tweet media one
1
5
11
0
0
3
@NAlsuhebany
Nada Alsuhebany
4 years
@EMPharmD_Rob @connermball Creative! No wonder why you’re an ER dude haha!
0
0
3
@NAlsuhebany
Nada Alsuhebany
2 years
Join us tomorrow at 2:30 PM!
@sopa_sos
SOPA
2 years
ECHELON-1 Study: Brentuximab Vedotin in Stage III or IV Hodgkins Lymphoma is the next journal club. Journal club Zoom link: Don't miss it tomorrow!
Tweet media one
0
6
8
0
2
3
@NAlsuhebany
Nada Alsuhebany
7 months
Say this list 3x fast, GO!! 🏃🏻‍♀️ Atezolizumab Bevacizumab Cetuximab Durvalumab Ipilimumab Panitumumab Pembrolizumab Mirvetuximab soravtansine Nivolumab Rituximab Sacituzumab govitecan Trastuzumab Tremelimumab
1
0
2
@NAlsuhebany
Nada Alsuhebany
2 years
@omaraalshaya @NAlkhani @abdulazizbofjer @RPh_Baker Thank you Dr. Omar for inviting us. It was a pleasure working with you.
0
0
2
@NAlsuhebany
Nada Alsuhebany
2 years
@Shaimalzaidi Congrats Shaima!!!! 😍❤️❤️❤️I wish you all the best
0
0
1
@NAlsuhebany
Nada Alsuhebany
4 years
@connermball "If you were a pizza deliveryman, how would you benefit from scissors?" - I found out later is it's one of Apple interview questions 😂
2
0
2
@NAlsuhebany
Nada Alsuhebany
3 years
@jesflres 🙋🏻‍♀️
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
@thisisJamesD Emailed you first thing once I found out 😎
0
0
1
@NAlsuhebany
Nada Alsuhebany
20 days
@_alenaziar Congrats Dr. Abeer! I had no doubts that you will make it one of the top three!! 🔥👏🏻
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
@thisisJamesD @ShockleyPharmD @lowvelo @MUSCPharmRes So fun! James you gotta be the preceptor of the wellness committee 😍
0
0
1
@NAlsuhebany
Nada Alsuhebany
4 years
MUSC PGY2 Oncology Program was accredited in 1997 🤩Impressive!
Tweet media one
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
@alshehriba2 Indeed it is! I always tell myself that I am a global citizen, I belong to every place, I belong to Mother Earth.
0
0
1
@NAlsuhebany
Nada Alsuhebany
4 years
Labetalol affinity to β-receptors is formulation dependent, with a β:α1 ratio of 7:1 in IV formulation vs 3:1 in PO formulation (PMID: 30521208).
0
0
1
@NAlsuhebany
Nada Alsuhebany
2 years
Join us tomorrow on our last journal club of the year!
@sopa_sos
SOPA
2 years
ROCKstar Study💡 Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy is the last journal club series for this year! Journal club link: Meeting ID: 828 4874 5125 Passcode: 250694 Don't miss it tomorrow!
Tweet media one
0
5
6
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
@Shaimalzaidi congrats!! 😍
0
0
1
@NAlsuhebany
Nada Alsuhebany
5 months
@Shaimalzaidi ألف ألف مبروك شيماء 😍💛الله يبارك وينفع بعلمك يارب 💛💛
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
Since it is the interview season, I am not gonna say “be yourself.” It is a cliché that I never understood. Rather I’d say practice to be yourself, practice to be the person you want to be.
0
1
1
@NAlsuhebany
Nada Alsuhebany
1 month
@_alenaziar Proud of you Abeer!!
0
0
1
@NAlsuhebany
Nada Alsuhebany
3 years
@thisisJamesD why all the papers after I am gone? 🥲Hope all is well, James!!!
0
0
1
@NAlsuhebany
Nada Alsuhebany
5 years
There are limited data how to manage cannabinoid hyperemesis syndrome but some studies showed ➡️ topical capsaicin 🌶️🌶️ is effective as a first line therapy! ✨Bonus trick: If topical capsaicin irritates any sensitive areas ➡️rinse milk🥛 to alleviate quickly!
1
0
1
@NAlsuhebany
Nada Alsuhebany
2 years
0
0
1
@NAlsuhebany
Nada Alsuhebany
2 years
@Dr_AmerZeidan Costa Rica :)
0
0
1
@NAlsuhebany
Nada Alsuhebany
5 months
@SultanJ87 @ITariq @alzahranim019 @Albekairy_AM @KSAU_HS_COP ألف مبروك سلطان 👏🏻👏🏻 ومن نجاح لنجاح يارب
1
0
1